Havana Cuba Business Travel Culture and Politics

Havana Cuba News

Cuba Culture News

Posted January 26, 2004 by publisher in Cuban Healthcare

Email this article | Print this article | Search Havana Journal        

[url=http://www.DTcuba.com]http://www.DTcuba.com[/url]

Havana.- The Cuban company CIMAB S.A., which commercializes the products of the Molecular Immunology Center, increased exports in 2003.
Company executives pointed out that new markets were explored last year, and production capacity was increased due to the introduction of state-of-the-art technology.

CIMAB S.A. has several joint ventures, including one in China and another in India.

The firm’s offers include the granulocytic colonies stimulating factor, erythropoietin, interferon, monoclonal antibodies and recombinant proteins, among others.

CIMAB S.A. also produces monoclonal drugs used to mitigate rejection of transplanted organs, mainly kidneys.

The latter is an immune suppressant that is commercialized in over a dozen countries, including Mexico, Argentina, Uruguay, El Salvador, India, China and Russia.

Would you like to add more information?


Only members can add more information. Please register or log in

  • Advertise at Havana Journal Inc
Images of Cuba
Jose Contreras shown at the 2000 Olympics
Follow Havana Journal
SUBSCRIBE to our Cuba Watch newsletter
LIKE us on Facebook

FOLLOW us on Twitter

CONNECT with us on Linked In

Section Archive
Havana Journal, Inc. BBB Business Review



Member of the Association for the Study of the Cuban Economy